Synagis 100 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FE8ZB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,111
Award facts
- Contract value 100% obligated
- $15,110.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,110.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Synagis 100 mg/ml vials. The contract, with an ultimate completion date of December 31, 2025, represents a non-competitive, competitively awarded transaction under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. Synagis (palivizumab) is a monoclonal antibody used primarily for respiratory syncytial virus (RSV) prophylaxis in high-risk pediatric populations, making this a specialized pharmaceutical procurement supporting military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The award reflects the contractor's established capability to meet federal procurement requirements and supply specialized medical commodities to the Defense Health Agency and other government healthcare systems through a flexible contract framework.
Quick answers
Who was awarded contract SPE2DR26FE8ZB?
SPE2DR26FE8ZB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FE8ZB worth?
The government has obligated $15,111 on SPE2DR26FE8ZB.
Is contract SPE2DR26FE8ZB an order under another contract?
Yes. SPE2DR26FE8ZB is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE8ZB competed?
The extent of competition for SPE2DR26FE8ZB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award